discover the recent advances in pricing and reimbursement pharmaceutical industry 21st & 22nd october 2002 hatton london a unique opportunity to learn from leading experts including dr robert freeman senior director public policy astrazeneca anita burrell global health economics research of outcomes aventis marion bamberger economic government affairs bristol myers squibb prof fabrizio gianfrate vice president general manager fondazione smithkline kate lynch merck sharp dohme chris teale product access allergan donald macarthur secretary european association euro companies eaepc kees de joncheere regional adviser pharmaceuticals world organisation who wouter van der meer strategic change services pricewaterhousecoopers benefits attending field understand opportunities threats challenges identify key issues surrounding find out about critical success factors take advantage networking meet decision makers supported by an outstanding programme with some genuinely novel important content gary johnson managing inpharmation plus half day interactive executive briefing calculating optimal price
